Trial intelligence / Profile preview

EVPOME vs AlloDerm for Mandibular Vestibuloplasty

NCT01834339Phase 2Terminated

Start
Sep 2013
Primary completion
Nov 2014
Modality
Implantable Devices, Implantable Hydrogels, Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of EVPOME in mandibular injury. Started Sep 2013; status: terminated.

02

Drugs

EVPOME
03

Conditions

mandibular injury

Beyond the preview

Go deeper on NCT01834339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01834339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call